Market Closed -
Bombay S.E.
12:07:50 2024-05-02 am EDT
|
5-day change
|
1st Jan Change
|
2,338
INR
|
-0.78%
|
|
+7.58%
|
-5.00%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,133
|
2,169
|
789.5
|
2,437
|
5,802
|
9,953
|
Enterprise Value (EV)
1 |
1,567
|
2,278
|
793.2
|
2,160
|
5,265
|
9,172
|
P/E ratio
|
11.7
x
|
6.03
x
|
4.65
x
|
13.9
x
|
10.9
x
|
17.7
x
|
Yield
|
-
|
-
|
-
|
-
|
1.55%
|
0.65%
|
Capitalization / Revenue
|
0.7
x
|
0.98
x
|
0.48
x
|
1.64
x
|
1.81
x
|
2.65
x
|
EV / Revenue
|
0.97
x
|
1.03
x
|
0.48
x
|
1.45
x
|
1.64
x
|
2.45
x
|
EV / EBITDA
|
7.52
x
|
4.32
x
|
2.87
x
|
6.4
x
|
6.91
x
|
12.2
x
|
EV / FCF
|
19.6
x
|
12.4
x
|
10.6
x
|
7.08
x
|
26.7
x
|
58.4
x
|
FCF Yield
|
5.11%
|
8.07%
|
9.44%
|
14.1%
|
3.75%
|
1.71%
|
Price to Book
|
8.96
x
|
4.52
x
|
1.21
x
|
2.93
x
|
4.34
x
|
5.4
x
|
Nbr of stocks (in thousands)
|
9,975
|
9,975
|
9,975
|
9,975
|
9,975
|
9,975
|
Reference price
2 |
113.6
|
217.4
|
79.15
|
244.3
|
581.7
|
997.8
|
Announcement Date
|
9/3/18
|
10/16/19
|
9/5/20
|
8/31/21
|
9/3/22
|
9/5/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,619
|
2,217
|
1,654
|
1,489
|
3,202
|
3,749
|
EBITDA
1 |
208.5
|
527.5
|
276.1
|
337.3
|
762.5
|
749.7
|
EBIT
1 |
159.1
|
447.6
|
229.7
|
252.5
|
706.5
|
686.4
|
Operating Margin
|
9.83%
|
20.19%
|
13.89%
|
16.96%
|
22.07%
|
18.31%
|
Earnings before Tax (EBT)
1 |
97.95
|
416.3
|
216.2
|
250.6
|
719.5
|
754.6
|
Net income
1 |
96.78
|
359.7
|
169.7
|
174.7
|
532.8
|
561.3
|
Net margin
|
5.98%
|
16.22%
|
10.26%
|
11.73%
|
16.64%
|
14.97%
|
EPS
2 |
9.700
|
36.06
|
17.02
|
17.52
|
53.42
|
56.27
|
Free Cash Flow
1 |
80.08
|
183.8
|
74.9
|
305.1
|
197.4
|
157.1
|
FCF margin
|
4.95%
|
8.29%
|
4.53%
|
20.49%
|
6.16%
|
4.19%
|
FCF Conversion (EBITDA)
|
38.4%
|
34.85%
|
27.13%
|
90.46%
|
25.89%
|
20.96%
|
FCF Conversion (Net income)
|
82.75%
|
51.11%
|
44.13%
|
174.6%
|
37.04%
|
27.99%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
9.000
|
6.500
|
Announcement Date
|
9/3/18
|
10/16/19
|
9/5/20
|
8/31/21
|
9/3/22
|
9/5/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
434
|
109
|
3.68
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
277
|
538
|
781
|
Leverage (Debt/EBITDA)
|
2.083
x
|
0.2062
x
|
0.0133
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
80.1
|
184
|
74.9
|
305
|
197
|
157
|
ROE (net income / shareholders' equity)
|
122%
|
119%
|
30%
|
23.5%
|
49.1%
|
35.3%
|
ROA (Net income/ Total Assets)
|
12.4%
|
27.7%
|
14.6%
|
15.1%
|
29.2%
|
19.8%
|
Assets
1 |
781.6
|
1,297
|
1,162
|
1,159
|
1,826
|
2,840
|
Book Value Per Share
2 |
12.70
|
48.10
|
65.40
|
83.40
|
134.0
|
185.0
|
Cash Flow per Share
2 |
0.0100
|
0.0100
|
0
|
2.390
|
6.940
|
3.910
|
Capex
1 |
7.96
|
22
|
105
|
87.4
|
153
|
149
|
Capex / Sales
|
0.49%
|
0.99%
|
6.33%
|
5.87%
|
4.79%
|
3.98%
|
Announcement Date
|
9/3/18
|
10/16/19
|
9/5/20
|
8/31/21
|
9/3/22
|
9/5/23
|
|
1st Jan change
|
Capi.
|
---|
| -5.00% | 282M | | +1.20% | 67.6B | | +44.29% | 40.33B | | +15.99% | 38.65B | | +4.67% | 32.55B | | +6.59% | 18.94B | | +12.32% | 16.76B | | +17.69% | 15.07B | | +8.31% | 14.83B | | -14.74% | 13.79B |
Other Commodity Chemicals
|